130000-78-1Relevant articles and documents
BIOACTIVE COMPOUNDS FOR TREATMENT OF CANCER AND NEURODEGENERATIVE DISEASES
-
Page/Page column 76, (2009/12/23)
The invention provides bioactive compounds for the treatment of various malconditions such as cancer and neurodegenerative diseases including Alzheimer's disease. The chemical compounds as disclosed herein are found to show bioactivity in bioassays related to these conditions. Pharmaceutical compositions, combinations and methods of synthesis are provided, as are methods of using the compound, compositions and combinations in the treatment of the diseases.
Origins of selectivity in a colorimetric charge-transfer sensor for diols
Rasberry, Roger D.,Smith, Mark D.,Shimizu, Ken D.
supporting information; experimental part, p. 2889 - 2892 (2009/05/11)
(Chemical Equation Presented) Bispyridyl hydrogen bonding receptor 1 forms colored charge transfer (CT) complexes with complementary phenols and naphthols. Despite its low association constants of ~101 M-1, receptor 1 was highly selective forming CT complexes of varying color and intensity with different diol guests. The selectivity of 1 was correlated with the ability of its CT band to simultaneously yield information about the association constant and the electronic structure of the phenols and naphthols.
3,5-dimethyl-4-methoxypyridine derivatives
-
, (2008/06/13)
A process for the preparation of compounds of formula I STR1 in which X is the radical OH or Cl, by the catalytic hydrogenation of 3,5-dimethyl-4-methoxy-2-cyanopyridine, subsequent reaction of the resulting 3,5-dimethyl-4-methoxy-2-aminomethylpyridine to give 3,5-dimethyl-4-methoxy-2-hydroxymethylpyridine and, if desired, chlorination to give 3,5-dimethyl-4-methoxy-2-chloromethylpyridine, and the novel intermediate 3,5-dimethyl-4-methoxy-2-aminomethylpyridine.